Advisors
NHSi has recruited a network of leading physicians and scientists to advise the management team,
lead academic investigations, and facilitate communications between NHSi and the scientific and medical
communities. These medical scientists are leaders in transcranial Doppler and neurosonology, surgery,
translational medicine, and red blood cell physiology.
Charles H. Tegeler, IV, M.D.,
McKinney-Avant Professor of Neurology, Director of the Neurosonology
Laboratory, and Head of the Section on Stroke and Cerebrovascular Disease, Wake Forest University
Dr. Tegeler is the McKinney-Avant Professor of Neurology, Director of the Neurosonology Laboratory,
and Head of the Section on Stroke and Cerebrovascular Disease. He also was the senior editor for the
textbook, Neurosonology (Mosby 1995). Dr. Tegeler is a past-president of the American Society of Neuroimaging (ASN),
and has been Chairman of the ASN Neurosonology Examination Committee, Director of the Neurosonology Program
at the ASN Annual Meeting, and Associate Editor of the Journal of Neuroimaging, for which he remains a member
of the Editorial Board. He is the Alternate Delegate to the AMA House of Delegates for the ASN, and represents
the NC Neurological Society as a member of the NC Medicare Carrier Advisory Committee. He has been President
of the Neuroimaging Section of the American Academy of Neurology, and represented the AAN on the Board of Directors,
and been Chairman of the Transcranial Doppler Committee, of the Intersocietal Commission for Accreditation of Vascular
Laboratories (ICAVL) from 1990-1999. Dr. Tegeler has been Treasurer of the Neurosonology Research Group of the World
Federation of Neurology, and has been Secretary for the International Cerebral Hemodynamics Society. He is Director
of the Basic and Advanced Courses in Neurosonology offered at Wake Forest University School of Medicine, in conjunction
with the Center for Medical Ultrasound. He is in charge of the weekly Integrated Neurosonology Teaching Conference,
and Directs Fellowships in Stroke and Cerebrovascular Disease, and Neurosonology. He is also Co-Chair of the Stroke
Sub-Committee of the Neurosciences Service Line at WFUBMC.
Dr. Tegeler's research activities focus on various new uses of ultrasound in concussion, stroke and cerebrovascular disorders,
and the prevention and acute treatment of stroke. He participated in multiple stroke prevention trials including CATS, TASS, SPAF-I,
and NASCET, and acute stroke treatment trials using Ancrod, Nimodipine, Citicoline, Lubeluzole, Pro-urokinase, and Clomethiazole.
He was Principal Investigator (PI) for Prevalence and Natural History of Emboli in Stroke (RO1-NS30720), PI for the ultrasound
reading center for SECORDS (NINDS), Co-I for the Ultrasound Reading Center for ARIC (NHLBIHC92-17), and is on the TCD Committee
for SONIA (NINDS). He was PI for industry sponsored research projects, including Carotid Volume Flow in Normal Subjects (Philips
Ultrasound International), Effect of Imitrex on NTG-induced Headache using TCD (S2B-150: Glaxo), Carotid Thrombus Imaging with DMP-444
(DuPont Merck), and was Co-I for Emboli in Severe Left Ventricular Dysfunction (THISL: DuPont), and Paraspinal Ultrasound in Normal Subjects
(SonoMed). He was PI for TCD in Epilepsy (NCBH Developmental Technology Grant), and has also been involved in numerous other minor
or unfunded projects.
James P. AuBuchon, M.D
President & CEO, Puget Sound Blood Center
Dr. AuBuchon serves as the President and CEO of the Puget Sound Blood Bank and as Professor of Medicine and Laboratory Medicine
at the University of Washington. Dr. AuBuchon was formerly the E. Elizabeth French Professor and Chair of Pathology at Dartmouth
Medical School. He is a member of the Board of Directors of the American Association of Blood Banks, Vice Chair of the Transfusion
Medicine Resource Committee in the College of American Pathologists, and served as the director of Dartmouth-Hitchcock’s Blood Bank
and Transfusion Service. He is also a Fellow of the College of American Pathologists and the Royal College of Physicians (Edinburgh).
Dr. AuBuchon is a well-known expert in the field of decision analysis and blood safety. He received his training at the University
of Michigan and the University of Wisconsin and was a senior staff fellow at the National Institutes of Health.
Larry J. Dumont, Ph.D., M.B.A.
Assistant Professor of Pathology, Director Cell Labeling Lab; Dartmouth-Hitchcock Medical Center
Dr. Dumont serves as Assistant Professor of Pathology at Dartmouth Medical School and Director of the Cell Labeling Laboratory.
He has extensive experience in experimental design and data analysis both in the industrial and clinical settings. His current interests
are in platelet physiology, in vivo cell survival kinetics, and clinical outcomes in transfusion medicine.
Effective October 2010, Dr. Dumont was elected to a four-year term as Chair of BEST Collaborative, an international research organization
that works collaboratively to explore ways to improve transfusion-related services through standardization of analytic techniques, development
of new procedures and execution of clinical trials in hemotherapy. Dr. Dumont has been an active member of BEST since 1992, and has served on
the Executive Committee and Co-Leader of the Clinical Studies Team during the past 4 years.
Dr. Dumont received his B.S. in Biology at Regis College, Denver, and M.B.A. from the University of Phoenix. He was awarded a Ph.D. in
Clinical Sciences at the University of Colorado Health Sciences Center in Denver where he received training in biostatistics and epidemiology.